Genetic disruption of ATAT1 causes RhoA downregulation through abnormal truncation of C/EBPβ.
Choi JH, Jeong J, Kim J, You E, Keum S, Song S, Hwang YE, Ji M, Park KS, Rhee S., Free PMC Article

Dysregulation of TNF-induced protein 3 and CCAAT/enhancer-binding protein β in alveolar macrophages: Implications for systemic sclerosis-associated interstitial lung disease.
Hua X, Hongbing R, Juan X, Jizan L, Beibei Y.

rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC.
Polcaro G, Liguori L, Manzo V, Chianese A, Donadio G, Caputo A, Scognamiglio G, Dell'Annunziata F, Langella M, Corbi G, Ottaiano A, Cascella M, Perri F, De Marco M, Col JD, Nassa G, Giurato G, Zeppa P, Filippelli A, Franci G, Piaz FD, Conti V, Pepe S, Sabbatino F., Free PMC Article

MiR-155-5p improves the insulin sensitivity of trophoblasts by targeting CEBPB in gestational diabetes mellitus.
Zhang H, Jiang Y, Zhu S, Wei L, Zhou X, Gao P, Zhang J, Chen Y, Du Y, Fang C, Su R, Li J, Wang S, Feng L.

[C/EBPβ mediates expressions of downstream inflammatory factors of the tumor necrosis factor-α signaling pathway in renal tubular epithelial cells with NPHP1 knockdown].
Huang D, Liu Y, Li D, Zhang J, Yang Y, Sun L., Free PMC Article

Transcriptional factor CCAAT enhancer binding protein beta inhibits epithelial-mesenchymal transition in cervical cancer via regulating attractin-like 1.
Fang M, Zhou Y, Li Z, Li X.

Assessing the double-edged of extracellular signal-regulated kinase/CCAAT-enhancer-binding protein beta signaling pathway in arsenic-induced skin damage and its potential foodborne interventions.
Yang F, Hu D, Du S, Wu L, Gong M, Zhang Y, Yang X, Yang Y, Chen R, Xu Y, Zeng Q.

Activation of BZW1 by CEBPB in macrophages promotes eIF2α phosphorylation-mediated metabolic reprogramming and endoplasmic reticulum stress in MRL/lpr lupus-prone mice.
Qi H, Zheng Z, Liu Q., Free PMC Article

CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response.
Westin ER, Khodadadi-Jamayran A, Pham LK, Tung ML, Goldman FD., Free PMC Article

Inhibition of abnormal C/EBPβ/α-Syn signaling pathway through activation of Nrf2 ameliorates Parkinson's disease-like pathology.
Lin Z, Huang L, Cao Q, Luo H, Yao W, Zhang JC., Free PMC Article

CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation.
Qi L, Sun B, Yang B, Lu S.

C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells.
Klempnauer KH., Free PMC Article

CEBPB upregulates P4HA2 to promote the malignant biological behavior in IDH1 wildtype glioma.
Wang S, Wu J, Zhao W, Li M, Li S.

C/EBPβ Coupled with E2F2 Promoted the Proliferation of hESC-Derived Hepatocytes through Direct Binding to the Promoter Regions of Cell-Cycle-Related Genes.
Liu S, Wang J, Chen S, Han Z, Wu H, Chen H, Duan Y., Free PMC Article

C/EBPβ expression decreases in cervical cancer and leads to tumorigenesis.
Long H, Li Y, Wang H, Guo B, Song S, Zhe X, Li H, Li D, Shao R, Pan Z., Free PMC Article

C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC.
Hartl L, Roelofs JJTH, Dijk F, Bijlsma MF, Duitman J, Spek CA., Free PMC Article

C/EBPβ Regulates TFAM Expression, Mitochondrial Function and Autophagy in Cellular Models of Parkinson's Disease.
Sierra-Magro A, Bartolome F, Lozano-Muñoz D, Alarcón-Gil J, Gine E, Sanz-SanCristobal M, Alonso-Gil S, Cortes-Canteli M, Carro E, Pérez-Castillo A, Morales-García JA., Free PMC Article

Analysis of DYRK1B, PPARG, and CEBPB Expression Patterns in Adipose-Derived Stem Cells from Patients Carrying DYRK1B R102C and Healthy Individuals During Adipogenesis.
Armanmehr A, Jafari Khamirani H, Zoghi S, Dianatpour M.

CEBPB regulates the bile acid receptor FXR to accelerate colon cancer progression by modulating aerobic glycolysis.
Wang Z, Pang J, Wang L, Dong Q, Jin D., Free PMC Article

CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma.
Yang J, Xu Y, Xie K, Gao L, Zhong W, Liu X., Free PMC Article

Inhibition of CEBPB Attenuates Lupus Nephritis via Regulating Pim-1 Signaling.
Wang X, Cheng W, Chen X, Gong Y, Wang G, Zhang X, Qi Y., Free PMC Article

CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.
Rong L, Chen B, Liu K, Liu B, He X, Liu J, Li J, He M, Zhu L, Liu K, Shi X, Shuai Y, Jin L., Free PMC Article

CEBPB is required for NRF2-mediated drug resistance in NRF2-activated non-small cell lung cancer cells.
Okazaki K, Anzawa H, Katsuoka F, Kinoshita K, Sekine H, Motohashi H.

A synthetic covalent ligand of the C/EBPβ transactivation domain inhibits acute myeloid leukemia cells.
Abdel Ghani L, Yusenko MV, Frank D, Moorthy R, Widen JC, Dörner W, Khandanpour C, Harki DA, Klempnauer KH.

C/EBPβ is a key transcription factor of ox-LDL inducing THP-1 cells to release multiple pro-inflammatory cytokines.
Ma J, Yang X, Chen X.